|
Beryl Drugs Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
9.64 Cr.
|
P/BV
|
1.04
|
Book Value (Rs.)
|
18.30
|
|
52 Week High/Low (Rs.)
|
30/16
|
FV/ML
|
10/1
|
P/E(X)
|
16.66
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
1.14
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | PR |
| FaceValue | 10.00 | 10.00 |
| | | |
| | | |
| INCOME | | |
| Revenue From Operations [Net] | 15.25 | 11.27 |
| Other Operating Revenues | 0.74 | 0.26 |
| Total Operating Revenues | 15.99 | 11.53 |
| Total Revenue | 15.99 | 11.53 |
| | | |
| EXPENSES | | |
| Cost Of Materials Consumed | 8.91 | 6.94 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.45 | -0.45 |
| Employee Benefit Expenses | 0.73 | 0.98 |
| Finance Costs | 0.13 | 0.20 |
| Depreciation And Amortisation Expenses | 0.33 | 0.38 |
| Other Expenses | 4.21 | 3.84 |
| Total Expenses | 14.76 | 11.89 |
| | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1.23 | -0.36 |
| | | |
| Profit/Loss Before Tax | 1.23 | -0.36 |
| | | |
| Tax Expenses-Continued Operations | | |
| Current Tax | 0.23 | 0.05 |
| Total Tax Expenses | 0.23 | 0.05 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 0.99 | -0.41 |
| | | |
| Profit/Loss From Continuing Operations | 0.99 | -0.41 |
| | | |
| Profit/Loss For The Period | 0.99 | -0.41 |
| Consolidated Profit/Loss After MI And Associates | 0.99 | -0.41 |
| | | |
| OTHER INFORMATION | | |
| | | |
| EARNINGS PER SHARE | | |
| Basic EPS (Rs.) | 1.96 | 0.00 |
| Diluted EPS (Rs.) | 1.96 | 0.00 |
